Electrocautery Ablation for the Prevention of Lung Cancer

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

September 2, 2022

Study Completion Date

October 11, 2022

Conditions
Lung Cancer Squamous Cell
Interventions
PROCEDURE

Electrocautery Ablation (EC)

For the purposes of the trial, one round of EC treatment consists of two individual EC treatments with a post-EC bronchoscopy in between to check for a response to the 1st EC treatment. Within each round, the second EC treatment will only be administered if the post-treatment bronchoscopy confirms presence of persistent high grade disease. Patients in the intervention arm will receive up to three rounds of EC treatment (no more than one round annually) to all their HGLs identified at baseline.

Trial Locations (1)

Unknown

UCLH, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER